MediGene AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other
pharmaceutical manufacturers in Europe:
sales of 6.17 million Euro [US$6.61 million]
of which 100%
was Research & Development),
Biotec Pharmacon ASA
(53.28 million Norwegian Kroner [US$6.31 million]
of which 56%
was BetaGlucans), and
based in Norway
(38.76 million Norwegian Kroner [US$4.59 million]
MediGene AG reported sales of 6.81 million Euro (US$7.30 million)
December of 2015.
decrease of 50.6%
versus 2014, when the company's sales were 13.78 million Euro.